115 related articles for article (PubMed ID: 37209464)
1. Diagnostic performance of Kaiser score in patients with newly diagnosed breast cancer: Factors associated with false-negative results.
Avdan Aslan A; Gültekin S
Eur J Radiol; 2023 Jul; 164():110864. PubMed ID: 37209464
[TBL] [Abstract][Full Text] [Related]
2. Assessment of breast lesions by the Kaiser score for differential diagnosis on MRI: the added value of ADC and machine learning modeling.
Chen ZW; Zhao YF; Liu HR; Zhou JJ; Miao HW; Ye SX; He Y; Liu XM; Su MY; Wang MH
Eur Radiol; 2022 Oct; 32(10):6608-6618. PubMed ID: 35726099
[TBL] [Abstract][Full Text] [Related]
3. Added value of clinical decision rules for the management of enhancing breast MRI lesions: A systematic comparison of the Kaiser score and the Göttingen score.
Dietzel M; Bernathova M; Clauser P; Kapetas P; Uder M; Baltzer PAT
Eur J Radiol; 2023 Dec; 169():111185. PubMed ID: 37939606
[TBL] [Abstract][Full Text] [Related]
4. Using the Kaiser Score as a clinical decision rule for breast lesion classification: Does computer-assisted curve type analysis improve diagnosis?
Pötsch N; Vatteroni G; Clauser P; Rainer E; Kapetas P; Milos R; Helbich TH; Baltzer P
Eur J Radiol; 2024 Jan; 170():111271. PubMed ID: 38185026
[TBL] [Abstract][Full Text] [Related]
5. Fusion of high b-value diffusion-weighted and unenhanced T1-weighted images to diagnose invasive breast cancer: factors associated with false-negative results.
Kim JJ; Kim JY
Eur Radiol; 2021 Jul; 31(7):4860-4871. PubMed ID: 33443601
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
7. The added value of apparent diffusion coefficient and microcalcifications to the Kaiser score in the evaluation of BI-RADS 4 lesions.
Pan J; Huang X; Yang S; Ouyang F; Ouyang L; Wang L; Chen M; Zhou L; Du Y; Chen X; Deng L; Hu Q; Guo B
Eur J Radiol; 2023 Aug; 165():110920. PubMed ID: 37320881
[TBL] [Abstract][Full Text] [Related]
8. False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features.
Alikhassi A; Li X; Au F; Kulkarni S; Ghai S; Allison G; Freitas V
Breast Cancer Res Treat; 2023 Apr; 198(2):321-334. PubMed ID: 36740611
[TBL] [Abstract][Full Text] [Related]
9. Can DWI provide additional value to Kaiser score in evaluation of breast lesions.
An Y; Mao G; Ao W; Mao F; Zhang H; Cheng Y; Yang G
Eur Radiol; 2022 Sep; 32(9):5964-5973. PubMed ID: 35357535
[TBL] [Abstract][Full Text] [Related]
10. Application of the Kaiser score by MRI in patients with breast lesions by ultrasound and mammography.
Wang Q; Fu F; Chen Y; Yang D; Zhang J; Yu H; Su L
Diagn Interv Radiol; 2022 Jul; 28(4):322-328. PubMed ID: 35950276
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of the Kaiser score for characterizing lesions on breast MRI with comparison to a multiparametric classification system.
Istomin A; Masarwah A; Vanninen R; Okuma H; Sudah M
Eur J Radiol; 2021 May; 138():109659. PubMed ID: 33752000
[TBL] [Abstract][Full Text] [Related]
12. Breast MRI: does a clinical decision algorithm outweigh reader experience?
Pötsch N; Korajac A; Stelzer P; Kapetas P; Milos RI; Dietzel M; Helbich TH; Clauser P; Baltzer PAT
Eur Radiol; 2022 Oct; 32(10):6557-6564. PubMed ID: 35852572
[TBL] [Abstract][Full Text] [Related]
13. Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.
Rong X; Kang Y; Xue J; Han P; Li Z; Yang G; Shi G
Eur Radiol; 2022 Nov; 32(11):7439-7447. PubMed ID: 35639141
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of Kaiser score combined with breast vascular assessment from breast MRI for the characterization of breast lesions.
Zhou XZ; Liu LH; He S; Yao HF; Chen LP; Deng C; Li SL; Zhang XY; Lai H
Front Oncol; 2023; 13():1165405. PubMed ID: 37483510
[TBL] [Abstract][Full Text] [Related]
15. Correct determination of the enhancement curve is critical to ensure accurate diagnosis using the Kaiser score as a clinical decision rule for breast MRI.
Grippo C; Jagmohan P; Helbich TH; Kapetas P; Clauser P; Baltzer PAT
Eur J Radiol; 2021 May; 138():109630. PubMed ID: 33744507
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.
Brennan ME; Houssami N; Lord S; Macaskill P; Irwig L; Dixon JM; Warren RM; Ciatto S
J Clin Oncol; 2009 Nov; 27(33):5640-9. PubMed ID: 19805685
[TBL] [Abstract][Full Text] [Related]
17. Evidence-Based and Structured Diagnosis in Breast MRI using the Kaiser Score.
Baltzer PAT; Krug KB; Dietzel M
Rofo; 2022 Nov; 194(11):1216-1228. PubMed ID: 35613905
[TBL] [Abstract][Full Text] [Related]
18. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
[TBL] [Abstract][Full Text] [Related]
19. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Clauser P; Dietzel M; Weber M; Kaiser CG; Baltzer PA
Acta Radiol; 2019 Jan; 60(1):19-27. PubMed ID: 29667880
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the differentiation of benign and malignant breast lesions using synthetic relaxometry and the Kaiser score.
Meng L; Zhao X; Guo J; Lu L; Cheng M; Xing Q; Shang H; Wang K; Zhang B; Lei D; Zhang X
Front Oncol; 2022; 12():964078. PubMed ID: 36303839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
